CYTOSORBENTS CORP (CTSO:NASDAQ)
$0.611 0.0061 (1.0084%)
Analysed CYTOSORBENTS CORP (CTSO:NASDAQ) News Sources
CTSO: CytoSorbents Reports Strong 4th Quarter and Full Year 2025 Results
06-04-2026
yahoo.com
Cytosorbents (CTSO) Q4 2025 Earnings Transcript
26-03-2026
fool.com
Cytosorbents Corporation Q4 2025 Earnings Call Summary
26-03-2026
moby.co
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ...
26-03-2026
yahoo.com
CytoSorbents: Q4 Earnings Snapshot
25-03-2026
yahoo.com
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
25-03-2026
yahoo.com
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
19-03-2026
yahoo.com
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
05-03-2026
yahoo.com
Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO) Before Long
14-02-2026
yahoo.com
CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross Margins
13-01-2026
yahoo.com
What is the current price of CYTOSORBENTS CORP (CTSO:NASDAQ)?
The current price of CYTOSORBENTS CORP (CTSO:NASDAQ) is $0.611.
CYTOSORBENTS CORP (CTSO:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYTOSORBENTS CORP (CTSO:NASDAQ) since the previous trading day is $0.0061.
CYTOSORBENTS CORP (CTSO:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYTOSORBENTS CORP (CTSO:NASDAQ) since the previous trading day is 1.0084%.
What is the most recent average sentiment score for CYTOSORBENTS CORP (CTSO:NASDAQ)?
The most recent average sentiment score for CYTOSORBENTS CORP (CTSO:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for CYTOSORBENTS CORP (CTSO:NASDAQ)?
The most recent sentiment for CYTOSORBENTS CORP (CTSO:NASDAQ) is .
SEC-8K** Filing Available For CYTOSORBENTS CORP (CTSO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.